⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ADAG News
Adagene Inc. American Depositary Shares
Adagene Provides Business Update and 2026 Objectives
globenewswire.com
ADAG
Adagene Announces FDA Fast Track Designation for Muzastotug (ADG126)
globenewswire.com
ADAG
MRK
Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
globenewswire.com
ADAG
Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer
globenewswire.com
ADAG